Alembic Pharmaceuticals (NSE:APLLTD, BOM:533573) has received an establishment inspection report from the US Food and Drug Administration (US FDA) for its injectable facility (F-III) at Karakhadi in Gujarat, India, according to a Thursday filing to the Indian stock exchanges.
The USFDA has inspected the facility between Feb. 9 and Feb. 18.
The company's shares were up nearly 2% in recent trade.